PHOENIX, Oct. 29, 2017 (GLOBE NEWSWIRE) — INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), today made the following statement about the Department of Justice (DOJ) investigation.
PHOENIX, Oct. 29, 2017 (GLOBE NEWSWIRE) — INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), today made the following statement about the Department of Justice (DOJ) investigation.